Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC

被引:20
作者
Liang, MN [1 ]
Lee, C [1 ]
Xia, Y [1 ]
McConnell, HM [1 ]
机构
[1] STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305
关键词
D O I
10.1021/bi961725b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used molecular modeling to design substitutions in an invariant chain-derived peptide (CLIP), so as to alter the stability of its complex with class II major histocompatibility complex (MPIC) proteins. We sought first to test whether CLIP binds in the same way to different class II MHC proteins. We designed destabilizing substitutions of two residues (Met 91 and Met 99) previously predicted to act as the major anchor residues for binding to all class II MHC and measured their effect on CLIP's dissociation rate from a series of three murine I-A MHC proteins. Even a conservative substitution preserving size and hydrophobicity but reducing flexibility (leucine, a branched residue) caused large accelerations in dissociation rates (up to 25-fold) at either position in all three MHC alleles, supporting the consistent role of these positions as the major anchors for MHC binding. These data also support the view that the special flexibility of the methionine side chains at these positions is essential for binding to diverse MHC molecules. We also used molecular modeling to design allele-specific enhancements of peptide binding. Designed substitutions of CLIP Pro 96 by Ala (for A(d)), Glu (A(k)), and Tyr (A(u)) each yielded strong enhancement of binding (up to 128-fold) for their targeted allele and only moderate or destabilizing effects to the other alleles. These results demonstrate the accuracy of the molecular models and the predictive value of this modeling. Moreover, they provide strong evidence far the proposed general model of invariant chain association, indicating that it binds to all class II MHC in the same conformation.
引用
收藏
页码:14734 / 14742
页数:9
相关论文
共 52 条
[1]   IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES [J].
AVVA, RR ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (09) :763-774
[2]   EVIDENCE FOR INVARIANT CHAIN-85-101 (CLIP) BINDING IN THE ANTIGEN-BINDING SITE OF MHC CLASS-II MOLECULES [J].
BANGIA, N ;
WATTS, TH .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (10) :1585-1591
[3]   The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C [J].
Barber, LD ;
Percival, L ;
Valiante, NM ;
Chen, L ;
Lee, C ;
Gumperz, JE ;
Phillips, JH ;
Lanier, LL ;
Bigge, JC ;
Parekh, RB ;
Parham, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :735-740
[4]   Isomeric complexes of peptides with class II proteins of the major histocompatibility complex [J].
Beeson, C ;
Anderson, TG ;
Lee, C ;
McConnell, HM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (05) :977-980
[5]   REACTIONS OF PEPTIDES WITH CLASS-II PROTEINS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX [J].
BEESON, C ;
MCCONNELL, HM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (42) :10429-10433
[6]   KINETIC INTERMEDIATES IN THE REACTIONS BETWEEN PEPTIDES AND PROTEINS OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II [J].
BEESON, C ;
MCCONNELL, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8842-8845
[7]   CORRELATION BETWEEN INVARIANT CHAIN EXPRESSION LEVEL AND CAPABILITY TO PRESENT ANTIGEN TO MHC CLASS II-RESTRICTED T-CELLS [J].
BERTOLINO, P ;
FORQUET, F ;
PONT, S ;
KOCH, N ;
GERLIER, D ;
RABOURDINCOMBE, C .
INTERNATIONAL IMMUNOLOGY, 1991, 3 (05) :435-443
[8]  
BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707
[9]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[10]   AUTOLOGOUS PEPTIDES CONSTITUTIVELY OCCUPY THE ANTIGEN-BINDING SITE ON IA [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
GREY, HM .
SCIENCE, 1988, 242 (4881) :1045-1047